BioCentury
ARTICLE | Regulation

Tracking FDA’s TrialBlazer reforms

Some actions are already complete, but the biggest changes to IND review, IRBs and trial enrollment remain ahead

June 24, 2026 10:25 PM UTC

FDA has taken a series of incremental steps over the last year to speed Phase I trial starts. Operation TrialBlazer maps more ambitious reforms.

At least one of the planned actions, establishing a a single IRB of record for multi-site industry trials, would require formal rulemaking, a process that can take more than a year. ...